126 related articles for article (PubMed ID: 8499603)
1. Anti-neurone antibodies are not characteristic of amyotrophic lateral sclerosis.
Kiernan JA; Hudson AJ
Neuroreport; 1993 Apr; 4(4):427-30. PubMed ID: 8499603
[TBL] [Abstract][Full Text] [Related]
2. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).
Niebroj-Dobosz I; Dziewulska D; Janik P
Folia Neuropathol; 2006; 44(3):191-6. PubMed ID: 17039414
[TBL] [Abstract][Full Text] [Related]
3. ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures.
Demestre M; Pullen A; Orrell RW; Orth M
J Neurochem; 2005 Jul; 94(1):268-75. PubMed ID: 15953369
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement.
Pullen AH; Demestre M; Howard RS; Orrell RW
Acta Neuropathol; 2004 Jan; 107(1):35-46. PubMed ID: 14551798
[TBL] [Abstract][Full Text] [Related]
5. Neuronal targets of serum and cerebrospinal fluid autoantibodies in amyotrophic lateral sclerosis.
Greiner A; Schmausser B; Petzold K; Krüger H; Marx A
Acta Neuropathol; 1996; 91(1):67-71. PubMed ID: 8773148
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of monoclonal immunoglobulins in serum of patients with amyotrophic lateral sclerosis.
Duarte F; Binet S; Lacomblez L; Bouche P; Preud'homme JL; Meininger V
J Neurol Sci; 1991 Jul; 104(1):88-91. PubMed ID: 1919600
[TBL] [Abstract][Full Text] [Related]
7. Subcellular localization of IgG from the sera of ALS patients in the nervous system.
Engelhardt JI; Soós J; Obál I; Vigh L; Siklós L
Acta Neurol Scand; 2005 Aug; 112(2):126-33. PubMed ID: 16008539
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.
Yi FH; Lautrette C; Vermot-Desroches C; Bordessoule D; Couratier P; Wijdenes J; Preud'homme JL; Jauberteau MO
J Neuroimmunol; 2000 Sep; 109(2):211-20. PubMed ID: 10996223
[TBL] [Abstract][Full Text] [Related]
9. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis.
Engelhardt JI; Appel SH
Arch Neurol; 1990 Nov; 47(11):1210-6. PubMed ID: 2122877
[TBL] [Abstract][Full Text] [Related]
10. Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients.
Niebroj-Dobosz I; Jamrozik Z; Janik P; Hausmanowa-Petrusewicz I; Kwieciński H
Acta Neurol Scand; 1999 Oct; 100(4):238-43. PubMed ID: 10694928
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis related antigen, Le(Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis.
Yoshiyama Y; Yamada T; Asanuma K; Asahi T
Acta Neuropathol; 1994; 88(3):207-11. PubMed ID: 7810291
[TBL] [Abstract][Full Text] [Related]
12. Recruitment of activated microglia cells in the spinal cord of mice by ALS IgG.
Obál I; Jakab JS; Siklós L; Engelhardt JI
Neuroreport; 2001 Aug; 12(11):2449-52. PubMed ID: 11496127
[TBL] [Abstract][Full Text] [Related]
13. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits.
He BP; Strong MJ
Neuropathol Appl Neurobiol; 2000 Apr; 26(2):150-60. PubMed ID: 10840278
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.
Obál I; Klausz G; Mándi Y; Deli M; Siklós L; Engelhardt JI
J Neuroinflammation; 2016 May; 13(1):121. PubMed ID: 27220674
[TBL] [Abstract][Full Text] [Related]
15. Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis.
Mori F; Tanji K; Miki Y; Wakabayashi K
J Neuropathol Exp Neurol; 2009 Nov; 68(11):1200-6. PubMed ID: 19816197
[TBL] [Abstract][Full Text] [Related]
16. Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis.
Brown RH; Johnson D; Ogonowski M; Weiner HL
Neurology; 1987 Jan; 37(1):152-5. PubMed ID: 3099227
[TBL] [Abstract][Full Text] [Related]
17. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients.
Donnenfeld H; Kascsak RJ; Bartfeld H
J Neuroimmunol; 1984 Feb; 6(1):51-7. PubMed ID: 6368581
[TBL] [Abstract][Full Text] [Related]
18. Circulating neurotoxins in amyotrophic lateral sclerosis.
Roisen FJ; Donnenfeld H; Bartfeld H; Baxter J
Adv Neurol; 1982; 36():403-17. PubMed ID: 7180690
[No Abstract] [Full Text] [Related]
19. Serine proteases purified from sera of patients with amyotrophic lateral sclerosis (ALS) induce contrasting cytopathology in murine motoneurones to IgG.
Demestre M; Howard RS; Orrell RW; Pullen AH
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):141-56. PubMed ID: 16599943
[TBL] [Abstract][Full Text] [Related]
20. Effect of ALS IgG on motor neurons in organotypic spinal cord cultures.
Li B; Liu XY; Li Z; Bu H; Sun MM; Guo YS; Li CY
Can J Neurol Sci; 2008 May; 35(2):220-5. PubMed ID: 18574938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
